209 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
1 May 24
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results
4:06pm
safety profile.
◦Updated interim results of seizure and non-seizure outcomes from the BECOME-TSC survey of caregivers of patients with tuberous
8-K
EX-10.1
el20q6
25 Jan 24
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.1
czbb9kpyqovg6sj4 z8
8 Nov 23
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:07pm
8-K
EX-99.1
fe1ee0veizmhg
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
x2zv2dwq0yy goc0
22 Jun 23
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
gli66cs 62ak8elqbg
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
EX-99.1
bp9vdv wr
21 Dec 22
Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab
7:40am
8-K
EX-2.1
wl3uh
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm